These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 34918103)
1. Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol. Wang Z; Fong CY; Goh EML; Moy HY; Chan ECY J Anal Toxicol; 2023 Jan; 46(9):1016-1024. PubMed ID: 34918103 [TBL] [Abstract][Full Text] [Related]
2. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA. Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743 [TBL] [Abstract][Full Text] [Related]
3. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity. Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment. Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808 [TBL] [Abstract][Full Text] [Related]
6. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors. Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352 [TBL] [Abstract][Full Text] [Related]
7. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA. Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194 [TBL] [Abstract][Full Text] [Related]
8. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry]. Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209 [TBL] [Abstract][Full Text] [Related]
9. Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases. Wagmann L; Stiller RG; Fischmann S; Westphal F; Meyer MR Arch Toxicol; 2022 Oct; 96(10):2755-2766. PubMed ID: 35788413 [TBL] [Abstract][Full Text] [Related]
10. Feature-Based Molecular Network for New Psychoactive Substance Identification: The Case of Synthetic Cannabinoids in a Seized e-Liquid and Biological Samples. Magny R; Lefrère B; Roulland E; Auzeil N; Farah S; Richeval C; Gish A; Vodovar D; Labat L; Houzé P J Am Soc Mass Spectrom; 2024 Oct; 35(10):2276-2287. PubMed ID: 39186500 [TBL] [Abstract][Full Text] [Related]
11. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order. Drug Enforcement Administration, Department of Justice Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681 [TBL] [Abstract][Full Text] [Related]
13. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent. Drug Enforcement Administration, Department of Justice Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047 [TBL] [Abstract][Full Text] [Related]
14. The 2-alkyl-2 Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266 [TBL] [Abstract][Full Text] [Related]
15. Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples. Gu K; Qin S; Zhang Y; Zhang W; Xin G; Shi B; Wang J; Wang Y; Lu J J Pharm Biomed Anal; 2022 Oct; 220():114985. PubMed ID: 35985137 [TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA. Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775 [TBL] [Abstract][Full Text] [Related]
17. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018. Liu C; Jia W; Hua Z; Qian Z Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270 [TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems. Gampfer TM; Wagmann L; Belkacemi A; Flockerzi V; Meyer MR Arch Toxicol; 2021 Nov; 95(11):3539-3557. PubMed ID: 34453555 [TBL] [Abstract][Full Text] [Related]
19. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid. Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867 [TBL] [Abstract][Full Text] [Related]